US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.57

-0.2300-0.62%

Post-market: 36.570.00000.00%19:30 EDT

Volume:21.69K

Turnover:793.57K

Market Cap:95.45M

PE:- -

High:36.78

Open:36.78

Low:36.42

Close:36.80

52wk High:36.84

52wk Low:23.32

Shares:2.61M

Float Shares:2.61M

Volume Ratio:0.26

T/O Rate:0.83%

Dividend:0.26

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Regeneron Announces Investor Conference Presentations

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

US FDA Approves Regeneron's Rare Bone Disorder Drug

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Why 2026 is Biotech's Comeback Year

Moderna's Melanoma Vaccine Trial Achieves Breakthrough, Shares Surge Over 90%

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS

CSPC Innovation Subsidiary Initiates Phase Ib/II Clinical Trial for SYS6090

What This Top Biotech Fund is Buying Now

This Sector Is Experiencing a Major Surge

What We're Really Talking About When We Discuss Innovative Drugs Today

Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IBBQ/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.57,"timestamp":1787774400000,"preClose":36.8,"halted":0,"volume":21693,"hourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006249999999999915,"floatShares":2610001,"shares":2610001,"eps":0,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"08-26 16:00:00 EDT","open":36.78,"high":36.78,"low":36.42,"amount":793570.4408310001,"amplitude":0.009783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":36.8,"sharesOutstanding":2520001,"nav":36.70729,"aum":95806063.60729,"dividendRate":0.007044,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.76,"preClose":36.8,"latestTime":"09:29 EDT","volume":101,"amount":3712.795653,"timestamp":1787750998097,"change":-0.04,"changeRate":-0.001087,"amplitude":0.00097},"postHourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.260535,"impliedVol":0.0839,"impliedVolPercentile":0.3466},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2610001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.260535,"shares":2610001,"dividePrice":0.2576,"high":36.78,"amplitude":0.009783,"preClose":36.8,"low":36.42,"week52Low":23.315,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.57,"eps":0,"divideRate":0.007044,"volume":21693,"delay":0,"ttmEps":0,"open":36.78,"prevYearClose":28.3962,"prevWeekClose":36.29,"prevMonthClose":32.1008,"prevQuarterClose":32.66,"fiveDayClose":36.8205,"twentyDayClose":32.41,"sixtyDayClose":29.2526},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BQXX3F31.USD","LU0058720904.USD","LU1917777945.USD","IBB","REGN","BCDF","LU2095319765.USD","BK4588","LU2362541273.HKD","TBXU","IE00B64PRP62.GBP","LU2106854487.HKD","BBH","LU2362540622.SGD","SG9999014005.SGD","NDAQ","LU2237438978.USD","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434583.USD","IE00BN0W2T93.GBP","LU0889565916.HKD","LU0053666078.USD","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU1974910355.USD","LU0320765992.SGD","LU0823416689.USD","IE00B3QW5Z07.USD","LU0314104364.USD","LU0823434740.USD","LU2468319806.SGD","SG9999014039.USD","LU0109394709.USD","LU2210149790.SGD","SG9999014013.SGD","LU0882574055.USD","LU2023250504.SGD","BK4139","IE00BQXX3D17.EUR","BK4112","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0889565916.HKD","IBB","BK4588","LU0320765992.SGD","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","LU2106854487.HKD","BK4139","LU0289739699.SGD","LU1917777945.USD","LU0823434583.USD","LU0058720904.USD","REGN","IBBQ","LU2023250504.SGD","BK4585","LU0823434740.USD","LU2362540622.SGD","TBXU","LU0882574055.USD","LU0053666078.USD","LU0109394709.USD","LU0823416689.USD","BBH","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0114720955.EUR","LU2237438978.USD","TBXU","LU0053666078.USD","LU2023250504.SGD","BBH","LU0823434583.USD","LU0823416689.USD","IBB","LU2362541513.USD","LU2468319806.SGD","LU0882574055.USD","LABU","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU2362541273.HKD","BK4139","LU2089984988.USD","REGN","LU1974910355.USD","LU1917777945.USD","LU2106854487.HKD","LU0109394709.USD","LU2362540622.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0823434740.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420810","title":"Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420810","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420810?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:15","pubTimestamp":1787163346,"startTime":"0","endTime":"0","summary":"• Argus raised Amgen's price target and reiterated a Buy rating.\n• Second-quarter financial performance exceeded Wall Street revenue and earnings expectations.\n• Technical indicators show a MACD buy signal and RSI buy condition.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118745-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0889565916.HKD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","PBE","LU2089984988.USD","TBXU","LU1061106388.HKD","BBH","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","04332","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660272694","title":"US FDA Approves Regeneron's Rare Bone Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660272694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660272694?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162562,"startTime":"0","endTime":"0","summary":"US FDA approves Regeneron's rare bone disorder drugAug 19-The U.S. Food and Drug Administration on Wednesday approved Regeneron'sREGN.Oexperimental treatment fora rare genetic disorder after the drug significantly reduced abnormal bone formation in certain soft tissues.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2362541513.USD","LU0109394709.USD","LU2362541273.HKD","LU1917777945.USD","LU2362540622.SGD","BK4585","IBBQ","BK4588","LU0320765992.SGD","LU0882574055.USD","LU1974910355.USD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","LU0289739699.SGD","LU0823434740.USD","LU2089984988.USD","REGN","LU0058720904.USD","LU0823434583.USD","BK4139","LU2468319806.SGD","BBH","LU2023250504.SGD","IBB","TBXU","LU0114720955.EUR","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","LU0823434583.USD","LU2362541513.USD","LU0109394709.USD","IBB","REGN","BK4139","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","LU0320765992.SGD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2468319806.SGD","LU1974910355.USD","LU0053666078.USD","LU0058720904.USD","BBH","LU2237438978.USD","TBXU","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0823434740.USD","TBXU","LU1974910355.USD","BK4588","LU0823434583.USD","LU0289739699.SGD","LU0109394709.USD","LU2023250504.SGD","BK4585","BK4139","LU0053666078.USD","LU2106854487.HKD","IBB","LU0058720904.USD","IBBQ","LU2362541273.HKD","LU2362541513.USD","LU0114720955.EUR","LU2362540622.SGD","REGN","LU2237438978.USD","LU0320765992.SGD","BBH","LU0823416689.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427103","title":"Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427103?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","BK4139","BK4588","LU2237438978.USD","LU2362541513.USD","LU0823434740.USD","LU2023250504.SGD","LU0823434583.USD","LU2089984988.USD","LU2362541273.HKD","LU2468319806.SGD","LU0114720955.EUR","LU1917777945.USD","LU0320765992.SGD","IBBQ","LU0289739699.SGD","REGN","TBXU","LU2106854487.HKD","LU1974910355.USD","BK4585","IBB","LU0889565916.HKD","LU2362540622.SGD","LU0058720904.USD","BBH","LU0823416689.USD","LU0053666078.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421798","title":"Why 2026 is Biotech's Comeback Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421798?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:16","pubTimestamp":1787152560,"startTime":"0","endTime":"0","summary":"This article was originally published on April 1, 2026. It has been updated to reflect recent developments.After a rough past few years, the biotech sector looks to be turning a corner. Major pharmace","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","BK4534","XLV","LU1280957306.USD","PBE","LU2168564495.EUR","LU2324357040.USD","LU2112291526.USD","LU2746668461.USD","LU1267930730.SGD","THNR","WDNA","LLII","LU0820562030.AUD","LU0889565916.HKD","LU0061475181.USD","IBBQ","LU0354030438.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0109391861.USD","IE0004445239.USD","IE00BWXC8680.SGD","SG9999014906.USD","LU1232071149.USD","LU2089283258.USD","IE00BN29S564.USD","IE00B4JS1V06.HKD","LU2237438978.USD","SGXZ81514606.USD","LU1551013342.USD","MRNY","GDOC","BK4566","LU0097036916.USD","IE00B1BXHZ80.USD","LU1629891620.HKD","LU2237443549.SGD","SG9999018865.SGD","LU1720051017.SGD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2237443895.HKD","LU2264538146.SGD","HRTS","LU1127390331.HKD","LU1291159041.SGD","SG9999014880.SGD","IE0005OL40V9.USD","LU0106261372.USD","LU2168564149.EUR","LU2265009873.SGD","IYH","LU0198837287.USD","LU2237443382.USD","LU2750360997.AUD","LU1868836914.USD","LU2471134796.USD","IBB","LU1069344957.HKD","LU0256863902.USD","LU1712237335.SGD","IE0001KFT4U8.USD","TMED","SG9999013999.USD","LU0203202063.USD","LLYZ","LU2471134523.USD","IE0004445015.USD","SG9999017495.SGD","AMGN","RXL","LU1064131342.USD","FTXH","LU2168564222.USD","PJP","LU0672654240.SGD","LU2462591350.SGD","LU2360106947.USD","OZEM","LU0689472784.USD","LU1974910355.USD","LU0225283273.USD","LU2417539215.USD","LU2211815571.USD","LU1988902786.USD","BIB","SG9999015986.USD","LU2023250330.USD","BK4551","BK4568","IE00BK4W5L77.USD","LU2237443622.USD","LU0943347566.SGD","LU0114720955.EUR","LU0823416689.USD","LU0964807845.USD","LU2602419157.SGD","LU0154236417.USD","LU0385154629.USD","LU2491049909.HKD","NVOH","BK4599","BK4501","LU2462157665.USD","ELIS","LU0353189763.USD","IE00BK4W5M84.HKD","LU1868837300.USD","LU2028103732.USD","LU0316494557.USD","LU2491050071.SGD","BK4548","LU2213496289.HKD","IE00BJJMRY28.SGD","LU0823434583.USD","SG9999014914.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU0203201768.USD","BK4532","LU2063271972.USD","IXJ","LU0345770308.USD","LU0882574055.USD","LU1323610961.USD","IE00BJT1NW94.SGD","CANC","LU0109394709.USD","LU1093756168.USD","LU0708995401.HKD","LU2089284900.SGD","LU0882574139.USD","LU2106854487.HKD","SG9999001176.SGD","SGXZ31699556.SGD","LU2461242641.AUD","IE00BJJMRX11.SGD","MRNA","CURE","JDOC","04332","AGNG","LU2108987350.USD","LU2756315318.SGD","LU0158827781.USD","NVO","TRUH","LU0133085943.USD","TBXU","BK4585","LU1366192091.USD","LU0466842654.USD","LU2242652126.USD","LU2552382058.USD","LU1868837136.USD","LU0323591593.USD","VHT","LU2168563687.JPY","MHIP","LU1057294990.SGD","LU2023250504.SGD","IE00B7KXQ091.USD","LU2168564065.EUR","LU2361044949.HKD","MEDI","LU1551013425.SGD","BK4007","IE00BKVL7J92.USD","LU1720051108.HKD","LU0266013472.USD","LU2552382215.SGD","LU0456855351.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","LU2242646821.SGD","LU1145028129.USD","LU1035775433.USD","LGHT","IE00BZ1G4Q59.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU2237443978.SGD","BK4533","LU0471298777.SGD","LU0787776722.HKD","LU0868494617.USD","LU1571399168.USD","LU2491050154.USD","ILDR","LLY","LU0122379950.USD","LU0417517546.SGD","LU0238689110.USD","LU2456880835.USD","LU2552382132.HKD","LU1023059063.AUD","LU2361044865.SGD","LU0058720904.USD","IE00B775H168.HKD","LU2471134879.HKD","LU0079474960.USD","LU0158827948.USD","MEDX","LU0683600562.USD","PPH","LU2896262040.SGD","SG9999015945.SGD","LU0320765992.SGD","LU1868836757.USD","LU0345770993.USD","LU2357305700.SGD","LU2111349929.HKD","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU0234572021.USD","SG9999001176.USD","SGXZ99366536.SGD","LLYX","LU0006306889.USD","LU2361045086.USD","LU0320765059.SGD","IHE","LU1093756325.SGD","BBH","LU2087625088.SGD","LU0354030511.USD","LU2750360641.GBP","NVOX","LU2236285917.USD","LU0094547139.USD","SG9999015952.SGD","LU1989771016.USD","LU0432979614.USD","LU1548497426.USD","LU1804176565.USD","LU2756315664.SGD","LU0174119429.USD","FHLC","LU1623119135.USD","IE00BFSS7M15.SGD","LU0640476718.USD","GB00BDT5M118.USD","LU0786609619.USD","LU2023251221.USD","LU1979441026.SGD","IDNA","LU1814569148.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","GNOM","LU1983299246.USD","SG9999015978.USD","ELIL","IE00B2B36J28.USD","SG9999018857.SGD","SGXZ51526630.SGD","LU0471298694.HKD","BK4588","LU0353189680.USD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0820561818.USD","LU0289739699.SGD","LU1868836591.USD","MRNX","SG9999001440.SGD","LU1061106388.HKD","LU0210536198.USD","LU2471134952.CNY","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100645668","title":"Moderna's Melanoma Vaccine Trial Achieves Breakthrough, Shares Surge Over 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100645668","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100645668?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:50","pubTimestamp":1787147459,"startTime":"0","endTime":"0","summary":"American vaccine manufacturer Moderna has seen its stock price soar by more than 90% following the announcement of successful clinical trial results for an investigational skin cancer vaccine. On...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","159646","PSYK","IBBQ","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426691","title":"Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426691?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:45","pubTimestamp":1787147100,"startTime":"0","endTime":"0","summary":"DJ Merck, Amgen Share Gains Contribute To Dow's 161-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Merck  and Amgen  have contributed to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 161 points higher .Merck's shares have climbed $12.37  while those of Amgen are up $13.30 , combining for an approximately 153-point bump for the Dow.Other components contributing significantly to the gain include Sherwin-Williams Co. , Home Depot , and Salesforce .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDOW","04332","LU0106261372.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU1066051811.HKD","LU0203345920.USD","BIB","LU1585245621.USD","LU1116320901.HKD","SG9999001440.SGD","XLV","IE00BLSP4452.SGD","JDOC","LU0859254822.USD","LU2491050071.SGD","MGK","LU1974910355.USD","LU0265550946.USD","LU1037948541.HKD","LU0320765992.SGD","SDY","LU0320765489.SGD","LU2089984988.USD","LU2491050154.USD","LU0823416689.USD","LU1989772923.USD","PPH","LU0070302665.USD","AMGN","LU2361045086.USD","LU1989772840.SGD","LU1917777945.USD","YMAX","LU2106854487.HKD","LU2360032135.SGD","LU1934455277.USD","LU0689626769.HKD","IE00BSNM7G36.USD","LU1093756168.USD","RXL","XLI","LU2242652126.USD","MYMmain","DJIA","SG9999014567.USD","LU0942090050.USD","LU1983299246.USD","LU0965509283.SGD","LU0130102774.USD","IE00BLSP4239.USD","BK4534","LU0109394709.USD","LU2125154935.USD","DVY","LU1066051225.USD","LU0130517989.USD","TBXU","LU2023250504.SGD","DGRO","LU0203347892.USD","DOG","LU1061106388.HKD","VYMI","BK4581","TOPT","LU0265550359.USD","LU0985320562.USD","IE00BFTCPJ56.SGD","SCHD","LU0266013472.USD","LU1023059063.AUD",".DJI","IE00B1BXHZ80.USD","PBE","LU0648001328.SGD","LU0122379950.USD","LU1035773651.USD","FDN","DDM","SG9999001176.SGD","LU1989771016.USD","LU2433249047.HKD","SG9999014575.USD","SG9999002232.USD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU1201861249.SGD","IXJ","LU0211331839.USD","LU2112291526.USD","SG9999002224.SGD","LU1923622614.USD","IYH","BMED","SG9999015358.SGD","LU0289739699.SGD","BK4559","BK4566","SCHG","DXD","IE00BJT1NW94.SGD","LU0868494708.USD","LU2361044865.SGD","HRTS","SDOW","VYM","PAWZ","LU1162221912.USD","LU1941712348.USD","PJP","BK4599","GRNY","BK4588","LU1934455863.HKD","SGXZ57979304.SGD","MRK","IHE","LU1699723380.USD","BK4139","DGRW","LU1093756325.SGD","VUG","LU0006306889.USD","LU2491049909.HKD","DIA","LU0124676726.USD","LU2468319806.SGD","LU0477156953.USD","IBB","LU2023250843.SGD","IE00BBT3K403.USD","BK4533","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","FDVV","BK4550","BK4585","LU1571399168.USD","LU1037948897.HKD","LU2361044949.HKD","VHT","LU2357627491.SGD","SG9999001176.USD","LU1291159041.SGD","SG9999014542.SGD","FHLC","LU0980610538.SGD","LU1929549753.HKD","LU2461242641.AUD","TRUH","BK4516","IBBQ","LU0238689110.USD","LU0320765646.SGD","LU0432979614.USD","LU1116320737.USD","BBH","LU2242646821.SGD","BK4007","IE00B2B36J28.USD","LU1430594728.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1069347547.HKD","IE0009355771.USD","LU1934455194.USD","DJX","SG9999013999.USD","LU0965509010.AUD","LU0098860793.USD","LU1941712264.USD","LU0058720904.USD","FTXH","LU0889565916.HKD","LU2125154778.USD","IE0002141913.USD","LU2324357040.USD","LU2125909593.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","GDOC","LU0234572021.USD","SG9999014559.SGD","LU0965509101.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","LU1255011170.USD","BK0196","LNGR","600276","LU0405327148.USD","LU2097828714.EUR","LU1997244956.HKD","LU1064130708.USD","LU1969619763.USD","01276","LU1023057109.AUD","LU2580892862.HKD","LU1820825898.SGD","LU2495084118.USD","LU1064131003.USD","BK0183","LU0405327494.USD","LU1328615791.USD","LU1997245094.SGD","LU1146622755.USD","06978","LU2148510915.USD","LU0359201885.HKD","LU1580142542.USD","LU1997245177.USD","LU2097828474.EUR","IBBQ","LU0359202008.SGD","MEDX","LU2543165471.USD","LU2097828557.USD","159992","BK0060","BK1161","BK1574","BK1191","LU2580892789.USD","LU2488822045.USD","LU2289578879.USD","BK0239","LU2097828805.USD","BK0012","LU2328871848.SGD","BK0188","LU0359201612.USD","LU1655091616.SGD","LU2097828631.EUR","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142854","title":"BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142854?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:04","pubTimestamp":1787141066,"startTime":"0","endTime":"0","summary":"BetterLife Pharma names Mahan Chehrenama chief medical officerBetterLife Pharma named Mahan Chehrenama as chief medical officer to lead clinical development of BETR-001.BETR-001 is advancing toward an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL40h7WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","AMGN","PBE","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0868494617.USD","LU0320765992.SGD","LU1023059063.AUD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0122379950.USD","IE0002141913.USD","BK4139","BK4588","LU0058720904.USD","BIB","LU2112291526.USD","BK4533","LU0109394709.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4599","BK4566","BBH","LU2089984988.USD","LU2242646821.SGD","BK4534","IBB","PJP","LU1061106388.HKD","TBXU","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344705","title":"Amgen Inc : Argus Research Raises Target Price to $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344705?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:25","pubTimestamp":1787138742,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU2468319806.SGD","BIB","BBH","AMGN","SG9999001440.SGD","TBXU","LU0889565916.HKD","LU0320765992.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4534","BK4585","BK4139","IE0002141913.USD","BK4533","IBB","IE00BFTCPJ56.SGD","LU1983299246.USD","LU0868494617.USD","BK4581","LU2242652126.USD","PBE","BK4588","IE00B2B36J28.USD","BK4566","IE0009355771.USD","LU1057294990.SGD","PJP","LU2112291526.USD","IE00B4R5TH58.HKD","BK4599","LU1023059063.AUD","LU2089984988.USD","LU1571399168.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0109394709.USD","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169059614","title":"CSPC Innovation Subsidiary Initiates Phase Ib/II Clinical Trial for SYS6090","url":"https://stock-news.laohu8.com/highlight/detail?id=1169059614","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169059614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:04","pubTimestamp":1787126666,"startTime":"0","endTime":"0","summary":"Cspc Innovation Pharmaceutical Co., Ltd. (300765.SZ) has announced that its controlling subsidiary, CSPC Megalith Biopharmaceutical Co., Ltd., recently kicked off a Phase Ib/II clinical trial...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IBBQ","IBBJ","PSYK","BK0226","MDTX","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660417405","title":"What This Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2660417405","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660417405?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:30","pubTimestamp":1787121000,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU2462157665.USD","LU0353189680.USD","IE0009355771.USD","LU2468319806.SGD","LU0889566641.SGD","LU1037948897.HKD","LU2242646821.SGD","LU0170899867.USD","LU1732799900.SGD","LU1162221912.USD","LU2168563687.JPY","LU0823416689.USD","SGXZ99366536.SGD","BK4504","IE00B775H168.HKD","IE00BN0W2V16.EUR","LU2028103732.USD","IE000SO60NU8.SGD","IE00BZ9MQY76.HKD","LU0683600562.USD","JNJ","LLYX","IE00BVYPNV92.GBP","IE00BK4W5L77.USD","LU2023250504.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","LU1868836757.USD","LU2063271972.USD","LU2746668461.USD","HRTS","LU2491050071.SGD","IE00BWXC8680.SGD","LU0158827948.USD","LLII","LU1066053197.SGD","LU2602419157.SGD","TMED","LU1548497426.USD","BK4567","LU2505996681.GBP","LU0289739699.SGD","SG9999011175.SGD","LU0426412945.USD","LU2237443549.SGD","LU2362541273.HKD","SG9999014914.USD","LU0882574139.USD","LU1061106388.HKD","LU1929549753.HKD","SG9999015952.SGD","LU0203202063.USD","IE0002141913.USD","BK4550","BK4533","XBI","LU2237443622.USD","IE00BKPKM429.USD","LU0069063385.USD","LU2106854487.HKD","LU0128525929.USD","SG9999001176.USD","TRUH","LU0820562030.AUD","BIB","LU0154245756.USD","WDNA","LU0133085943.USD","LU2237438978.USD","LU0198837287.USD","LU1043141396.HKD","LU1127390331.HKD","LU2750360997.AUD","LU0792757196.USD","LU1093756325.SGD","LU1506573853.SGD","LU1934455277.USD","IE000F7OJYX1.SGD","LU0471298694.HKD","LU1291159041.SGD","LU2487616109.SGD","LU2361044949.HKD","LU1074936037.SGD","LU0354030511.USD","IE00B19Z9Z06.USD","LU1228905540.USD","LU0820561818.USD","LU0964807845.USD","LU0097036916.USD","BBH","LU2237443465.HKD","LU2129689514.USD","LU0109391861.USD","LU0787776722.HKD","BK4583","BK4559","LU1032955483.USD","LU1670628061.USD","LU1989772923.USD","BMED","LU2361045086.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU0029864427.USD","BK4578","IE00BJJMRY28.SGD","LU1043141123.HKD","LU1232071149.USD","BK4581","IE0004445239.USD","LU0234570918.USD","BK4592","LU2362540622.SGD","IE00BJJMRZ35.SGD","REGN","LU0949170772.SGD","IE00BLSP4239.USD","LU2089283258.USD","LU0098860793.USD","SG9999001176.SGD","CURE","LU1035775433.USD","IE000WAW04H5.SGD","LU0158827781.USD","LU1267930813.SGD","XLV","IHE","LU0094547139.USD","LU1989772840.SGD","LU2347655073.USD","LU0057025933.USD","GB00BDT5M118.USD","IE00BN0W2T93.GBP","IBB","IE00BGHQF631.EUR","LU1037948541.HKD","IE00B3PB1722.GBP","LU2324357040.USD","LU0994945656.USD","LU2023251221.USD","PBE","LU1935042991.SGD","IE00B3T34201.USD","LU1267930730.SGD","LU1623119135.USD","IE00BBT3K403.USD","LU0310800379.SGD","LU2756315318.SGD","LU0726765562.USD","LU1778281490.HKD","LU1718418525.SGD","LU1280957306.USD","LU0965509101.SGD","BK4566","LU2756315664.SGD","AMGN","IE000MB6IJN5.SGD","IE00BFSS7M15.SGD","LU0320765059.SGD","IE00BSNM7G36.USD","LU0985320562.USD","LU2347655156.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999001440.SGD","BK4588","BK4532","BK4568","LU0795875169.SGD","LU2087625088.SGD","LU1923622614.USD","GNMX","LU2362541513.USD","LU0965509010.AUD","LU0211327993.USD","LU1496350502.SGD","CANC","LU0345769128.USD","LU1983299246.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","MEDX","IE00BDGV0183.EUR","LU1003077747.HKD","LU1496350171.SGD","IE00B4JS1V06.HKD","SG9999013999.USD","BK4534","GLAM","LU0385154629.USD","LU2211815571.USD","LU1066051811.HKD","LU0426417589.USD","LU0203201768.USD","LU2552382132.HKD","LU0965509283.SGD","TBXU","IXJ","LU1093756168.USD","LU1670627923.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","ILDR","LU0072461881.USD","LU0889565916.HKD","LU0466842654.USD","LU1267930573.SGD","BK4007","LU1814569148.SGD","VRTX","IE00BK4W5M84.HKD","SGXZ81514606.USD","LU2456880835.USD","LU1934455194.USD","JDOC","IE0004445015.USD","LU1914381329.SGD","LU0124676726.USD","LU0823434740.USD","LU1059921491.USD","LU1121112475.USD","IE000BZT7R73.USD","IE00BJLML261.HKD","LU2236285917.USD","LU0162691827.USD","LU0210528500.USD","LU0316494557.USD","LU1712237335.SGD","LU0096364046.USD","LU2242652126.USD","LU1988902786.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","SG9999018865.SGD","PPH","LU2237443895.HKD","OZEM","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1979441026.SGD","LU1894683348.USD","LU2271345857.HKD","LU0395794307.EUR","LU2357627491.SGD","SG9999002232.USD","LU0456855351.SGD","LU2471134952.CNY","LU2357305700.SGD","LU2087621335.USD","LU2265009873.SGD","FHLC","JAZZ","LU2264538146.SGD","IE0000B7K699.USD","LU2168564495.EUR","LU1894683264.USD","PJP","LU0553294199.USD","LU1868836914.USD","LU2433249047.HKD","XDNA","LU0289739343.SGD","LU2168564222.USD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU0672654240.SGD","LU1917777945.USD","LU0965508806.USD","LU2491050154.USD","LU1145028129.USD","LU0472753341.HKD","LU1720051108.HKD","LU2461242641.AUD","LU0545039389.USD","LU0786609619.USD","LLY","LU0256863902.USD","SG9999014898.SGD","BK4139","LU0203347892.USD","04332","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU0061475181.USD","LU0861579265.USD","LU0345770993.USD","LU2237443978.SGD","SG9999017495.SGD","BK4516","IBBQ","IE000M9KFDE8.USD","LU1057294990.SGD","LU2403377893.USD","VHT","LU2089284900.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1323610961.USD","LU0320765646.SGD","LU2361044865.SGD","LU2430703178.SGD","LU1066051225.USD","LU0640476718.USD","LU0079474960.USD","THNR","LU1720051017.SGD","IE00BN29S564.USD","LU1868837300.USD","ABBV","LU1804176565.USD","SGXZ31699556.SGD","IE0002270589.USD","RXL","IE00BN0W2W23.USD","LU2168564149.EUR","LLYZ","LU2750360641.GBP","IE00BVYPNW00.USD","LU2896262040.SGD","LU0417517546.SGD","LU2125909247.SGD","LU1267930490.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","IYH","LU0942090050.USD","IE00BFXG1179.USD","LU0234572021.USD","LU1196500208.SGD","LU0174119429.USD","LU2129689605.HKD","LU0882574055.USD","LU1674673428.USD","LU2111349929.HKD","MEDI","LU2746668974.SGD","LU2552382215.SGD","LU0738911758.USD","LU2430703251.USD","LU1221951129.SGD","IE00B2B36J28.USD","BK4599","LU2471134523.USD","LU1732800096.USD","LU0868494708.USD","LU0345770308.USD","SG9999014880.SGD","FTXH","MHIP","LU0210536198.USD","IE00BN8TJ469.HKD","LU1839511570.USD","LU1430594728.SGD","LU1261432733.SGD","LU1244550577.SGD","LU1674673691.USD","LU2491049909.HKD","LU0310799852.SGD","LU1066051498.USD","LU0353189763.USD","LU2592432038.USD","LU2108987350.USD","LU1366192091.USD","AGNG","LU0545562505.USD","SG9999014906.USD","LU2237443382.USD","LU0943347566.SGD","LU0122379950.USD","LU0820561909.HKD","LU2125909593.SGD","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU0823434583.USD","LU1064131342.USD","LU1629891620.HKD","LU0154245673.USD","GILD","SG9999015945.SGD","LU2112291526.USD","ELIL","LU0795875086.SGD","LU0511384066.AUD","LU1244550221.USD","LU2023250330.USD","LU0070217475.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1023059063.AUD","LU0289961442.SGD","LU1551013342.USD","LU1244550494.USD","LU0106261372.USD","LU0203345920.USD","IE00BJJMRX11.SGD","ELIS","LU0912757837.SGD","SGXZ57979304.SGD","LU0471298777.SGD","LU2462591350.SGD","LU0320765992.SGD","LU0109394709.USD","LU1032466523.USD","LU0708994859.HKD","LU0859254822.USD","SGXZ80539844.SGD","SG9999015978.USD","IE00BKDWB100.SGD","IE00B42XCP33.USD","LU0058720904.USD","LU0868494617.USD","LU1974910355.USD","LU2129689431.USD","SG9999018857.SGD","LU0211328371.USD","LU2552382058.USD","LU0345769631.USD","SGXZ51526630.SGD","LU0256863811.USD","LU0323591593.USD","LU1585245621.USD","LU0661504455.SGD","LU1221951046.USD","LU0114720955.EUR","LU2417539215.USD","IE00B894F039.SGD","BK4585","LU2471134796.USD","IDNA","LU2133065610.SGD","LU0432979614.USD","IE00B19Z3581.USD","SG9999015986.USD","LU0354030438.USD","LU2360106947.USD","LU0053666078.USD","LU1069344957.HKD","LU2089984988.USD","LU1989771016.USD","LU1868837136.USD","IE0001KFT4U8.USD","LU0689472784.USD","LU2168564065.EUR","LU0225283273.USD","IE0034235303.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166888801","title":"This Sector Is Experiencing a Major Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1166888801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166888801?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:00","pubTimestamp":1787119253,"startTime":"0","endTime":"0","summary":"Since the technology sector cooled off in July, the innovative drug industry chain has taken the lead in market performance. The sector has risen considerably, with leading player Wuxi AppTec...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LNGR","BK1161","MEDX","06978","IBBQ","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178011845","title":"What We're Really Talking About When We Discuss Innovative Drugs Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1178011845","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178011845?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:20","pubTimestamp":1787109655,"startTime":"0","endTime":"0","summary":"When we talk about innovative drugs, we can't just look at innovative drugs alone. BD out-licensing, the scientific research services and CXO opportunities brought by AI-driven drug development, and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LNGR","BK1574","06978","BK1161","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109518315","title":"Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?","url":"https://stock-news.laohu8.com/highlight/detail?id=1109518315","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109518315?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:11","pubTimestamp":1787105475,"startTime":"0","endTime":"0","summary":"The biopharmaceutical sector has once again captured the spotlight in the financial markets. According to data from Gongmu Paipai.com, between August 3 and August 9, public offering institutions...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","06978","159992","MEDX","BK1574","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490195","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490195","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:54","pubTimestamp":1787093684,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier disposes of USD 3.86 million in common sharesGilead Chief Communications and Corporate Affairs Officer Johanna Mercier exercis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbJPzzx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0122379950.USD","IBB","IE00BZ1G4Q59.USD","LU0882574055.USD","LU0114720955.EUR","LU1066053197.SGD","LU0965509010.AUD","LU1674673428.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0234570918.USD","BIB","BMED","LU0320765992.SGD","IE00B7SZLL34.SGD","TMED","IBBQ","BBH","LU1430594728.SGD","SG9999015986.USD","LU1585245621.USD","TBXU","BK4583","BK4139","BK4585","LU2468319806.SGD","BK4566","LU2089984988.USD","LU0889565916.HKD","LU0965509101.SGD","LU1037948541.HKD","LU1057294990.SGD","LU2112291526.USD","LU2087621335.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","BK4532","LU0058720904.USD","BK4550","LU1066051498.USD","IE00B19Z3581.USD","LU0861579265.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","LU1934455277.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}